Top Markets
Coin of the day
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
Ранг среди акций #33273
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily... CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.
Цена акции
$5.47
Последняя синхронизация: 2026-08-14
Рыночная капитализация
$7.99M
Изменение (1 день)
6.21%
Изменение (1 год)
7.47%
Страна
US
Торговля CNS Pharmaceuticals, Inc. (CNSP)

Категория

История дроблений акций CNS Pharmaceuticals, Inc. (CNSP)
Акции CNS Pharmaceuticals, Inc. (символ: CNSP) прошли через 0 дроблений.
Последнее дробление произошло Aug 17, 2026.
Одна акция CNSP, купленная до Aug 17, 2026, сейчас соответствует 0 акциям CNSP.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE